(Q40840410)

English

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

scientific article

Statements

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule (English)
Hörig H
Conkright W
Divito J
Hasson H
LaMare M
Rivera A
Guito K
Tsang KW
Schlom J
Kaufman HL
1 November 2000
504-514

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit